Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Ants offer lead on new antibiotics
Scientists study unusual sources for new drugs

Current research could offer solutions to antibiotic resistance, as scientists investigate some unusual sources for new drugs, such as ants, stick insects, soil and even potatoes.

Researchers at the University of East Anglia (UEA) and John Innes Centre (JIC) in Norwich are studying South American leafcutter ants, most commonly known for marching in single file carrying leaf sections twice their size.

They can now be studied on "ant cam" as they manage their food source in the JIC insectary.

Leafcutter ants do not eat the leaf sections from plants but transport them underground, where they decay and form a fungus garden.

This research is at the very early stage but it is exciting to investigate new solutions to the increasing problem of antibiotic resistance.
The ants then protect this food source from unwanted microbes and parasites by cultivating bacteria on their own bodies to produce antibiotics. This also allows them to manage the growth of the fungus.

One such antibiotic discovered on the bodies of leafcutter ants is already used as an antifungal in modern medicine, but Dr Matthew Hutchings from the UEA hopes that brand new antibiotics could be discovered by studying the ants.

Scientists are also studying giant lime green stick insects, which feed on eucalyptus, and the death's head hawkmoth, which feeds primarily on potatoes.

Both of these food sources contain toxins which scientists believe could have antibacterial properties. Scientists know that the insects have been exposed to antibiotics through their food, as antibiotic-resistant bacteria has been found in their guts.

Researcher Katarzyna Ignasiak from the JIC, said: "This research is at the very early stage but it is exciting to investigate new solutions to the increasing problem of antibiotic resistance."

Work with soil bacteria at the JIC is at a more advanced stage. Professor Melvyn Bibb and colleagues at the centre can now manipulate soil bacteria Actinomycetes to make new antibiotics.

Research carried out in Prof. Bibb's laboratory have contributed to the progression of an antibiotic to Phase II clinical trials by Novacta Biosystems, a spin-out company of JIC.

Click here to view the ant cam.

Images courtesy of the John Innes Centre.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.